Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 14, 2014 - Issue 4
Submit an article Journal homepage
253
Views
9
CrossRef citations to date
0
Altmetric
Drug Profile

Brivaracetam for the treatment of epilepsy in adults

Marco MulaDepartment of Neurology, Epilepsy Group, St George’s Hospital,Blackshaw Road, London SW17 0QT, UKCorrespondence[email protected]
Pages 361-365 | Published online: 13 Mar 2014

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Emilio Russo, Rita Citraro & Marco Mula. (2017) The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy. Expert Opinion on Drug Discovery 12:11, pages 1169-1178.
Read now
Marco Mula. (2016) Third generation antiepileptic drug monotherapies in adults with epilepsy. Expert Review of Neurotherapeutics 16:9, pages 1087-1092.
Read now
Xin Tian, Meizhen Yuan, Qingju Zhou & Xuefeng Wang. (2015) The efficacy and safety of brivaracetam at different doses for partial-onset epilepsy: a meta-analysis of placebo-controlled studies. Expert Opinion on Pharmacotherapy 16:12, pages 1755-1767.
Read now
Steve Chung. (2014) USL255 extended-release topiramate for the treatment of epilepsy. Expert Review of Neurotherapeutics 14:10, pages 1127-1137.
Read now

Articles from other publishers (5)

Wenyue Dong, Peiyuan Yao, Yingang Wang, Qiaqing Wu & Dunming Zhu. (2020) Chemoenzymatic Stereoselective Synthesis of Substituted γ‐ or δ‐lactams with Two Chiral Centers via Transaminase‐catalysed Dynamic Kinetic Resolution. ChemCatChem 12:24, pages 6311-6316.
Crossref
Bassel Abou-Khalil. 2017. Epilepsy Board Review. Epilepsy Board Review 241 245 .
Jean‐Marie Nicolas, Jonas Hannestad, Daniel HoldenSophie Kervyn, Nabeel NabulsiDominique Tytgat, Yiyun HuangHugues Chanteux, Ludovicus Staelens, Alain Matagne, François‐Xavier Mathy, Joël Mercier, Armel Stockis, Richard E. CarsonHenrik Klitgaard. (2015) Brivaracetam, a selective high‐affinity synaptic vesicle protein 2A ( SV 2A) ligand with preclinical evidence of high brain permeability and fast onset of action . Epilepsia 57:2, pages 201-209.
Crossref
Kelly Mills & Zoltan Mari. (2014) An Update and Review of the Treatment of Myoclonus. Current Neurology and Neuroscience Reports 15:1.
Crossref
Megan Cully. (2014) Drug development: Illuminated targets. Nature 511:7508, pages S12-S13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.